Keytruda+Lenvima – SGO Display Banners Conference – 22405
Preoperative PET Scans Improve Management of Gynecologic Cancer
Apr 26, 2022
Preoperative PET scanning among patients with high-risk, clinical stage 1 endometrial cancer (EC)...
Immunotherapy Underutilized for Patients With Gynecologic Cancer
Apr 25, 2022
Immunotherapy is underutilized in patients with advanced endometrial cancer (EC), even though...
Increased Disparities Found in Cervical Cancer Screening Post-Pandemic
Apr 25, 2022
The COVID-19 pandemic had a major effect on access to gynecologic care for women of all races and...
BMI Impacts SLN Mapping in Gynecologic Cancer
Apr 25, 2022
Prior research has examined sentinel lymph node (SLN) mapping among patients with a range of BMI...
Gynecologic Cancer & the Negative Impacts of COVID-19
Mar 19, 2022
Among the disruptions in timely medical care caused by the COVID-19 pandemic is the receipt of...
Immunotherapy for Advanced Uterine Cancer Is Underutilized
Mar 19, 2022
The use of the FDA-approved checkpoint inhibitor pembrolizumab in clinical practice—for previously...
Uterine Cancer Benefits With Lenvatinib Plus Pembrolizumab Dose Reductions
Mar 19, 2022
The toxicity observed with full doses of lenvatinib and the underrepresentation of Black...
Text Messaging After Gynecologic Cancer Surgery Feasible & Effective
Mar 19, 2022
The standard of care following gynecologic oncology surgery may include post-discharge calls to...
Endometrial Hyperplasia Staging: Avoiding Reoperation With SLN Mapping
Mar 18, 2022
To determine whether sentinel lymph node mapping (SLN) in patients with endometrial hyperplasia is...
Self-Hypnosis Decreases Gynecologic Cancer Surgery Anxiety
Mar 18, 2022
With prior research indicating that self-hypnosis (SH) may help reduce preoperative distress and...
